Economic Burden of the Inadequate Management of Allergic Rhinitis and Urticaria in Asian Countries Based on the GA2LEN Model

被引:45
|
作者
Kulthanan, Kanokvalai [1 ]
Chusakul, Supinda [2 ]
Recto, Marysia Tiongco [3 ]
Gabriel, Ma Teresita [4 ]
Aw, Derrick Chen-Wee [5 ]
Prepageran, Narayanan [6 ]
Wong, Alson [7 ]
Leong, Jern Lin [8 ]
Foong, Henry [9 ]
Vo Thanh Quang [10 ]
Zuberbier, Torsten [11 ,12 ,13 ,14 ]
机构
[1] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Dermatol, Bangkok, Thailand
[2] Chulalongkorn Univ, Fac Med, Dept Otolaryngol, Bangkok, Thailand
[3] Univ Philippines, Philippine Gen Hosp, Dept Pediat, Sect Allergy & Immunol, Manila, Philippines
[4] Res Inst Trop Med, Dept Dermatol, Manila, Philippines
[5] Sengkang Hlth, Dept Gen Med, Singapore, Singapore
[6] Univ Malaya, Fac Med, Dept Otorhinolaringol, Kuala Lumpur, Malaysia
[7] Private Clin, Hong Kong, Hong Kong, Peoples R China
[8] ASCENT Ear Nose Throat Specialist Grp, Singapore, Singapore
[9] Foong Skin Specialist Clin, Ipoh, Malaysia
[10] Natl Hosp Otorhinolaryngol, Hanoi, Vietnam
[11] Charite, Berlin, Germany
[12] Free Univ Berlin, Berlin, Germany
[13] Humboldt Univ, Berlin, Germany
[14] Allergy Ctr Charite, Berlin Inst Hlth, Dept Dermatol & Allergy, Berlin, Germany
关键词
Allergic rhinitis; urticaria; socioeconomic costs; QUALITY-OF-LIFE; POSITRON-EMISSION-TOMOGRAPHY; ASTHMA; PREVALENCE; DISEASES; ANTIHISTAMINES; SENSITIZATION; SINGAPORE; LEVOCETIRIZINE; PRODUCTIVITY;
D O I
10.4168/aair.2018.10.4.370
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose: Across Hong Kong, Malaysia, the Philippines, Singapore, Thailand and Vietnam, (referred to as Asia) approximately 30-53 million individuals of the 151 million employed suffer from allergic rhinitis (AR) and urticaria. It is estimated that approximately 90% of patients with these allergic conditions are insufficiently treated, impacting the socioeconomic burden in terms of absence from work and decreased productivity. This study aims to estimate the socioeconomic burden of allergies in Asia and the cost savings that their adequate management can provide. Due to the limited availability of regional data, this study focused AR and urticaria in selected countries. Methods: Published literature, information from statistical bureaus, clinician surveys and extrapolation of selected data from the European Union were used to determine the socioeconomic costs of AR and urticaria. Results: Many patients in Asia suffer from perennial allergies and experience symptoms of AR and urticaria for up to 298 days per year. An estimate of the indirect costs of patients insufficiently treated for AR and urticaria amounts to USD 105.4 billion a year, which equates to USD 1,137-2,195 per patient due to absenteeism and presenteeism. Adherence to guideline-approved treatment can lead to estimated savings of up to USD 104 billion. Conclusions: The current study suggests that within Asia, the socioeconomic impact of AR and urticaria is similar to that seen in the European Union in spite of the lower wages in Asia. This is due to the mainly perennial allergens prevailing in Asia, whereas the sensitization patterns observed in the European Union are dominated by seasonal exposure to pollen. These results underline the need for governmental initiatives to increase public awareness on the prevention and treatment of these and other allergic diseases as well as greater research funding and large-scale studies to reduce their growing socioeconomic burden in coming years.
引用
收藏
页码:370 / 378
页数:9
相关论文
共 33 条
  • [1] Economic burden of inadequate management of allergic diseases in the European Union: a GA2LEN review
    Zuberbier, T.
    Loetvall, J.
    Simoens, S.
    Subramanian, S. V.
    Church, M. K.
    [J]. ALLERGY, 2014, 69 (10) : 1275 - 1279
  • [2] Efficacy of Desloratadine in Persistent Allergic Rhinitis - A GA2LEN Study
    Bousquet, Jean
    Bachert, Claus
    Canonica, Giorgio W.
    Mullol, Joaquim
    Van Cauwenberge, Paul
    Jensen, Carsten Bindslev
    Fokkens, Wystke J.
    Ring, Johannes
    Keith, Paul
    Gopalan, Gokul
    Lorber, Richard
    Zuberbier, Torsten
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2010, 153 (04) : 395 - 402
  • [3] EAACI/GA2LEN/EDF guideline:: management of urticaria
    Zuberbier, T
    Bindslev-Jensen, C
    Canonica, W
    Grattan, CEH
    Greaves, MW
    Henz, BM
    Kapp, A
    Kozel, MMA
    Maurer, M
    Merk, HF
    Schäfer, T
    Simon, D
    Vena, GA
    Wedi, B
    [J]. ALLERGY, 2006, 61 (03) : 321 - 331
  • [4] Efficacy of desloratadine in intermittent allergic rhinitis: a GA2LEN study
    Bousquet, J.
    Bachert, C.
    Canonica, G. W.
    Mullol, J.
    Van Cauwenberge, P.
    Jensen, C. Bindslev
    Fokkens, W. J.
    Ring, J.
    Keith, P.
    Lorber, R.
    Zuberbier, T.
    [J]. ALLERGY, 2009, 64 (10) : 1516 - 1523
  • [5] The Prevalence of Allergic Rhinitis in Southwestern Iran and Its Association with Chronic Rhinosinusitis: A GA2LEN Study
    Ostovar, Afshin
    Pordel, Safoora
    Movahed, Ali
    Kaboodkhani, Reza
    Akhlaghi, Allahkaram
    Darabi, Amirhossein
    Ghaderi, Farzaneh
    Farrokhi, Shokrollah
    [J]. IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2021, 20 (03) : 263 - 270
  • [6] GA2LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma
    Zuberbier, T.
    Bachert, C.
    Bousquet, P. J.
    Passalacqua, G.
    Canonica, G. Walter
    Merk, H.
    Worm, M.
    Wahn, U.
    Bousquet, J.
    [J]. ALLERGY, 2010, 65 (12) : 1525 - 1530
  • [7] Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN)
    Bousquet, J.
    van Cauwenberge, P.
    Khaled, N. Ait
    Bachert, C.
    Baena-Cagnani, C. E.
    Bouchard, J.
    Bunnag, C.
    Canonica, G. W.
    Carlsen, K. -H.
    Chen, Y. -Z.
    Cruz, A. A.
    Custovic, A.
    Demoly, P.
    Dubakiene, R.
    Durham, S.
    Fokkens, W.
    Howarth, P.
    Kemp, J.
    Kowalski, M. L.
    Kvedariene, V.
    Lipworth, B.
    Lockey, R.
    Lund, V.
    Mavale-Manuel, S.
    Meltzer, E. O.
    Mullol, J.
    Naclerio, R.
    Nekam, K.
    Ohta, K.
    Papadopoulos, N.
    Passalacqua, G.
    Pawankar, R.
    Popov, T.
    Potter, P.
    Price, D.
    Scadding, G.
    Simons, F. E. R.
    Spicak, V.
    Valovirta, E.
    Wang, D. -Y.
    Yawn, B.
    Yusuf, O.
    [J]. ALLERGY, 2006, 61 (09) : 1086 - 1096
  • [8] The management of the allergic child at school: EAACI/GA2LEN Task Force on the allergic child at school
    Muraro, A.
    Clark, A.
    Beyer, K.
    Borrego, L. M.
    Borres, M.
    Carlsen, K. C. Lodrup
    Carrer, P.
    Mazon, A.
    Rance, F.
    Valovirta, E.
    Wickman, M.
    Zanchetti, M.
    [J]. ALLERGY, 2010, 65 (06) : 681 - 689
  • [9] The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
    Zuberbier, T.
    Aberer, W.
    Asero, R.
    Latiff, A. H. Abdul
    Baker, D.
    Ballmer-Weber, B.
    Bernstein, J. A.
    Bindslev-Jensen, C.
    Brzoza, Z.
    Buense Bedrikow, R.
    Canonica, G. W.
    Church, M. K.
    Craig, T.
    Danilycheva, I. V.
    Dressler, C.
    Ensina, L. F.
    Gimenez-Arnau, A.
    Godse, K.
    Goncalo, M.
    Grattan, C.
    Hebert, J.
    Hide, M.
    Kaplan, A.
    Kapp, A.
    Katelaris, C. H.
    Kocaturk, E.
    Kulthanan, K.
    Larenas-Linnemann, D.
    Leslie, T. A.
    Magerl, M.
    Mathelier-Fusade, P.
    Meshkova, R. Y.
    Metz, M.
    Nast, A.
    Nettis, E.
    Oude-Elberink, H.
    Rosumeck, S.
    Saini, S. S.
    Sanchez-Borges, M.
    Schmid-Grendelmeier, P.
    Staubach, P.
    Sussman, G.
    Toubi, E.
    Vena, G. A.
    Vestergaard, C.
    Wedi, B.
    Werner, R. N.
    Zhao, Z.
    Maurer, M.
    [J]. ALLERGY, 2018, 73 (07) : 1393 - 1414
  • [10] Management of chronic spontaneous urticaria in accordance with the guidelines EAACI/GA2LEN/EDF/WAO
    Marin-Cabanas, Irene
    Bouret-Lebron, Angelica
    De Leon, Francisco
    Berbegal, Laura
    Francisco Silvestre, Juan
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB78 - AB78